S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
52-week Low Names To Tip The Upside Scale In Your Favor
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Analysts Went All In On These Computer Stocks, Save Your Spot
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
52-week Low Names To Tip The Upside Scale In Your Favor
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Analysts Went All In On These Computer Stocks, Save Your Spot
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
52-week Low Names To Tip The Upside Scale In Your Favor
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Analysts Went All In On These Computer Stocks, Save Your Spot
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
Enterprise Products: 7.33% Yield and 26-Years of Dividend Growth
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A Tech Stock You've Never Heard Of Just Hit The Rally Button
52-week Low Names To Tip The Upside Scale In Your Favor
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Is New IPO Instacart Already Hitting Speed Bumps?
Prospect Capital Corporation: A Gold Nugget or Value Trap?
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Analysts Went All In On These Computer Stocks, Save Your Spot
Seagen, Activision Blizzard rise; Scholastic, Intel fall, Friday, 9/22/2023
NASDAQ:NH

NantHealth (NH) Stock Forecast, Price & News

$0.47
+0.02 (+4.46%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.43
$0.47
50-Day Range
$0.30
$0.60
52-Week Range
$1.24
$9.75
Volume
998 shs
Average Volume
38,073 shs
Market Capitalization
$3.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

NH stock logo

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.

NH Price History

NH Stock News Headlines

NantHealth (NASDAQ:NH) Now Covered by StockNews.com
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Best Hospitals in New Hampshire
Best Hotels in North Conway, NH
Track Covid-19 in New Hampshire
See More Headlines
Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings
11/04/2021
Today
9/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
326
Year Founded
N/A

Profitability

Net Income
$-67,780,000.00
Pretax Margin
-95.06%

Debt

Sales & Book Value

Annual Sales
$67.68 million
Book Value
($30.72) per share

Miscellaneous

Free Float
2,981,000
Market Cap
$3.61 million
Optionable
Optionable
Beta
1.82
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Patrick Soon-ShiongPatrick Soon-Shiong
    Chairman & Chief Executive Officer
  • Ronald Allen LouksRonald Allen Louks
    Chief Operating Officer
  • Bob Petrou
    Chief Financial Officer
  • Tiffany Avery
    Chief Medical Officer
  • Brandon Villery
    Secretary, Senior Vice President & General Counsel













NH Stock - Frequently Asked Questions

How have NH shares performed in 2023?

NantHealth's stock was trading at $3.65 on January 1st, 2023. Since then, NH stock has decreased by 87.2% and is now trading at $0.4683.
View the best growth stocks for 2023 here
.

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) released its quarterly earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02. The firm earned $14.36 million during the quarter, compared to analyst estimates of $17.70 million. During the same quarter last year, the firm earned ($0.08) earnings per share.

What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?

82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How do I buy shares of NantHealth?

Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $0.47.

How much money does NantHealth make?

NantHealth (NASDAQ:NH) has a market capitalization of $3.61 million and generates $67.68 million in revenue each year. The company earns $-67,780,000.00 in net income (profit) each year or ($7.65) on an earnings per share basis.

How many employees does NantHealth have?

The company employs 326 workers across the globe.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (855) 949-6268 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -